title: Expression profiles of metabolic enzymes and drug transporters in the liver and along the intestine of beagle dogs.
abstract: Beagle dogs are widely used in preclinical pharmacokinetic, safety, and formulation studies. However, little is known about intestinal and hepatic distribution of major enzymes and transporters involved in oral absorption and presystemic drug metabolism. We characterized mRNA levels of CYP3A12, CYP3A26, CYP2D15, UGT1A6, ABCB1 (MDR1), ABCC1 (MRP1), ABCG2 (BCRP), SLC15A1 (PEPT1), and SLC22A1 (OCT1) in dog liver and along the intestine by real-time quantitative reverse transcription-polymerase chain reaction. Tissue protein levels of CYP2D15, MDR1, and PEPT1 were obtained by Western blot. Gene distribution and expression variability was statistically described by a generalized additive mixed model smoothing function and correspondence analysis. Results were compared with the expression pattern known for the human orthologs. Hepatic mRNA levels for metabolic enzymes were generally higher than those for membrane transporters, whereas in the intestine the opposite was observed. Hepatic mRNA levels followed the order CYP2D15 > UGT1A6 ≈ CYP3A26 > ABCB1 ≈ SLC15A1 ≈ SLC22A1 > ABCG2 > ABCC1 ≈ CYP3A12. Along the gut, the genes were differentially distributed with greatest expression in duodenum/upper jejunum (ABCG2), middle jejunum (ABCB1 and SLC15A1), or in cecum/colon (ABCC1 and CYP2D15). CYP3A12, CYP3A26, SLC22A1, and UGT1A6 had a rather uniform expression. Intestinal mRNA profiles of CYP2D15, ABCB1, and SLC15A1 correlated with the respective protein levels. Canine CYP3A12/26, CYP2D15, and ABCB1 colonic distributions differed from those of human orthologs, whereas UGT1A6, ABCC1, ABCG2, SLC15A1, and SLC22A1 were comparable to those of humans in both small and large intestine. We aim to apply these data to better interpret pharmacokinetic studies in dogs with respect to their human relevance.
authors.affiliation: Institute of Pharmaceutical Sciences, ETH-Zürich, Switzerland
authors.forename: Stephanie
authors.initials: S
authors.lastname: Haller
authors.forename: Franz
authors.initials: F
authors.lastname: Schuler
authors.forename: Stanley E
authors.initials: SE
authors.lastname: Lazic
authors.forename: Dalila
authors.initials: D
authors.lastname: Bachir-Cherif
authors.forename: Stefanie D
authors.initials: SD
authors.lastname: Krämer
authors.forename: Neil J
authors.initials: NJ
authors.lastname: Parrott
authors.forename: Guido
authors.initials: G
authors.lastname: Steiner
authors.forename: Sara
authors.initials: S
authors.lastname: Belli
mesh_terms: D000818:Animals; D004285:Dogs; D005260:Female; D020869:Gene Expression Profiling; D007413:Intestinal Mucosa / Q000378:metabolism; D007422:Intestines / Q000201:enzymology*; D008099:Liver / Q000201:enzymology* / Q000378:metabolism; D008297:Male; D020133:Reverse Transcriptase Polymerase Chain Reaction